Home > Insider Trading > Revance Therapeutics Inc.

Revance Therapeutics Inc. (RVNC)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

Revance Therapeutics, Inc. (NASDAQ:RVNC) Q2 2024 Earnings Call Transcript

Operator: Welcome to the Revance Therapeutics Second Quarter 2024 Financial Results And Corporate Update Conference Call. At this time, all participants are in a listen-only mode.

Keep Reading →

August 10th, 2024 - News Transcripts

Revance Therapeutics, Inc. (NASDAQ:RVNC) Q1 2024 Earnings Call Transcript

Operator: Welcome to the Revance Therapeutics First Quarter2024 Financial Results and Corporate Update Conference Call. At this time, all participants are in a listen-only mode.

Keep Reading →

May 10th, 2024 - News Transcripts

Revance Therapeutics, Inc. (NASDAQ:RVNC) Q4 2023 Earnings Call Transcript

Operator: Welcome to the Revance Therapeutics Fourth Quarter and Full Year 2023 Financial Results and Corporate Update Conference Call.

Keep Reading →

March 2nd, 2024 - News Transcripts

Revance Therapeutics, Inc. (NASDAQ:RVNC) Q3 2023 Earnings Call Transcript

Operator: Welcome to the Revance Therapeutics Third Quarter 2023 Financial Results and Corporate Update Conference Call. At this time, all participants are in a listen-only mode.

Keep Reading →

November 9th, 2023 - News Transcripts

13 Stocks to Buy with Exponential Growth

Optimism was prevailing in the US stock market on October 11 as investors were hopeful that the Federal Reserve won’t take a hawkish stance for the rest of the year amid rising bond yields that are ...

Keep Reading →

October 14th, 2023 - Hedge Funds News

Revance Therapeutics (RVNC) Shares Declined on Profit-Taking

Baron Funds, an investment management company, released its “Baron Discovery Fund” second quarter 2023 investor letter. A copy of the same can be downloaded here.

Keep Reading →

August 21st, 2023 - Hedge Fund Investor Letters News

Revance Therapeutics, Inc. (NASDAQ:RVNC) Q2 2023 Earnings Call Transcript

Operator: Welcome to the Revance Therapeutics Second Quarter 2023 Financial Results and Corporate Update Conference Call. At this time, all participants are in a listen-only mode.

Keep Reading →

August 10th, 2023 - News Transcripts

10 Oversold Biotech Stocks to Buy

In this article, we will take a look at the 10 oversold biotech stocks to buy.

Keep Reading →

July 29th, 2023 - Hedge Funds Lists Market Movers

10 Best Revenue Growth Stocks to Buy

In this piece, we will take a look at the ten best revenue growth stocks to buy.

Keep Reading →

July 13th, 2023 - Hedge Funds News

Here's Why Revance Therapeutics (RVNC) Outperformed in Q1

Baron Funds, an investment management company, released its “Baron Discovery Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here.

Keep Reading →

May 16th, 2023 - Hedge Fund Investor Letters News